Signal transduction inhibitors in treatment of myelodysplastic syndromes

Myelodysplastic syndromes (MDS) are a group of hematologic disorders characterized by ineffective hematopoiesis that results in reduced blood counts. Although MDS can transform into leukemia, most of the morbidity experienced by these patients is due to chronically low blood counts. Conventional cyt...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bachegowda, Lohith, Gligich, Oleg, Mantzaris, Ionnis, Schinke, Carolina, Wyville, Dale, Carrillo, Tatiana, Braunschweig, Ira, Steidl, Ulrich, Verma, Amit
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3716523/
https://ncbi.nlm.nih.gov/pubmed/23841999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-50
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados